The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of neighborhood deprivation on disability free survival in patients with aggressive B cell non-Hodgkin lymphoma.
 
Madelyn Burkart
No Relationships to Disclose
 
Nicholas Demetriou
No Relationships to Disclose
 
Ashwin Sunderraj
No Relationships to Disclose
 
Shou Ma
Honoraria - Abbvie; AstraZeneca; BeiGene; Bristol-Myers Squibb; Clinical Care Options; Curio Science; DAVA Oncology; Genentech; Janssen; Lilly O.; Medscape; OncLive; TG Therapeutics
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Bristol-Myers Squibb; Genentech; Janssen; TG Therapeutics
Speakers' Bureau - AstraZeneca; BeiGene; Janssen; Lilly O.; Pharmacyclics
Research Funding - Abbvie; AstraZeneca; BeiGene; Juno Therapeutics; Loxo; TG Therapeutics
 
Jane N. Winter
Honoraria - Merck
Consulting or Advisory Role - Agios (I); Ariad (I); Bristol-Myers Squibb (I); CVS Caremark (I); Epizyme (I); Gilead Sciences (I); Janssen (I); Merck; Novartis (I); Novartis (I); Takeda (I)
Research Funding - Astellas Pharma (I); Astellas Pharma (Inst); Celgene (I); Cellectis (I); Daiichi Sankyo (I); Forty Seven (I); Merck; Novartis (I)
Patents, Royalties, Other Intellectual Property - Royalties from UptoDate, Inc. (I)
 
Leo I. Gordon
Stock and Other Ownership Interests - Zylem
Consulting or Advisory Role - Epizyme; Gilead Sciences; Janssen Oncology; Karyopharm Therapeutics
Patents, Royalties, Other Intellectual Property - Zylem
 
Jonathan Moreira
Consulting or Advisory Role - CarelonRx
 
Reem Karmali
Honoraria - Bio Ascend; Prime Oncology
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Celgene/Juno; Calithera Biosciences; EUSA Pharma; Genentech/Roche; Gilead Sciences; Lilly; Miltenyi Biotec
Speakers' Bureau - AstraZeneca; BeiGene; MorphoSys/Incyte
Research Funding - BeiGene (Inst); Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); Miltenyi Biotec (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Prime Oncology
 
Ishan Roy
No Relationships to Disclose